CARRIE CONSALVI: Open Payments
NPI 1952743841 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 15 payments from 9 companies in 2025. Trend: 2023 $32 · 2024 $0 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $79 |
| Alnylam Pharmaceuticals Inc. | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Novo Nordisk Inc | 1 | $33 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Chiesi USA, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $24 |
Products named: CAMZYOS, ONPATTRO, LEQVIO, JARDIANCE, Wegovy, OPSUMIT, ELIQUIS, JUXTAPID.
Industry payments across MA — which companies pay providers there.
